Vascular injury during elevated glucose can be mitigated by erythropoietin and Wnt signaling.
Impacting a significant portion of the world's population with increasing incidence in minorities, the young, and the physically active, diabetes mellitus (DM) and its complications affect approximately 20 million individuals in the United States and over 100 million individuals worldwide. In particular, vascular disease from DM may lead to some of the most serious complications that can extend into both the cardiac and nervous systems. Unique strategies that can prevent endothelial cell (EC) demise and elucidate novel cellular mechanisms for vascular cytoprotection become vital for the prevention and treatment of vascular DM complications. Here, we demonstrate that erythropoietin (EPO), an agent that has recently been shown to extend cell viability in a number of systems extending beyond hematopoietic cells, prevents EC injury and apoptotic nuclear DNA degradation during elevated glucose exposure. More importantly, EPO employs Wnt1, a cysteine-rich glycosylated protein involved in gene expression, cell differentiation, and cell apoptosis, to confer EC cytoprotection and maintains the integrity of Wnt1 expression during elevated glucose exposure. In addition, application of anti-Wnt1 neutralizing antibody abrogates the protective capacity of both EPO and Wnt1, illustrating that Wnt1 is an important component in the cytoprotection of ECs during elevated glucose exposure. Intimately linked to this cytoprotection is the downstream Wnt1 pathway of glycogen synthase kinase (GSK-3beta) that requires phosphorylation of GSK-3beta and inhibition of its activity by EPO. Interestingly, inhibition of GSK-3beta activity during elevated glucose leads to enhanced EC survival, but does not synergistically improve protection by EPO or Wnt1, suggesting that EPO and Wnt1 are closely tied to the blockade of GSK-3beta activity. Our work exemplifies an exciting potential application for EPO in regards to the treatment of DM vascular disease complications and highlights a previously unrecognized role for Wnt1 and the modulation of the downstream pathway of GSK-3beta to promote vascular cell viability during DM.
Chong
Zhao Zhong
ZZ
Division of Cellular and Molecular Cerebral Ischemia, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Shang
Yan Chen
YC
Maiese
Kenneth
K
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001921:Brain / Q000166:cytology; D002470:Cell Survival / Q000187:drug effects; D053938:DNA Fragmentation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D042783:Endothelial Cells / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004921:Erythropoietin / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects*; D051155:Wnt1 Protein / Q000276:immunology / Q000378:metabolism* / Q000494:pharmacology
D000906:Antibodies; D004791:Enzyme Inhibitors; D051155:Wnt1 Protein; D004921:Erythropoietin; D005947:Glucose
Cancer Res. 2004 May 15;64(10):3474-8
15150100
J Am Coll Cardiol. 2004 Jul 7;44(1):63-7
15234408
Circulation. 2004 Aug 24;110(8):1006-12
15302785
Am J Hum Genet. 2004 Nov;75(5):832-43
15386214
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10228-33
8816781
Eur J Endocrinol. 1998 Oct;139(4):367-70
9820611
Diabetologia. 2004 Oct;47(10):1695-703
15502930
Neurology. 2004 Nov 23;63(10):1902-7
15557509
Neurosignals. 2004 Nov-Dec;13(6):265-89
15627815
JAMA. 2005 Jan 5;293(1):90-5
15632341
Cell. 2005 Jan 14;120(1):137-49
15652488
Diabetes. 2005 Feb;54(2):554-62
15677515
Trends Pharmacol Sci. 2004 Nov;25(11):577-83
15491780
Kidney Int. 1990 Nov;38(5):969-75
2266682
J Cell Sci. 1992 Sep;103 ( Pt 1):23-37
1429907
Diabet Med. 1994 Jun;11(5):475-9
8088126
Arch Intern Med. 2005 Feb 28;165(4):466-9
15738380
J Mol Neurosci. 2005;25(2):183-9
15784966
Oncogene. 2005 Apr 21;24(18):3054-8
15735684
J Am Coll Cardiol. 2005 May 3;45(9):1406-12
15862410
Prog Neurobiol. 2005 Feb;75(3):207-46
15882775
Brain Res Brain Res Rev. 2005 Jul;49(1):1-21
15960984
Curr Neurovasc Res. 2005 Jan;2(1):55-72
16181100
Curr Neurovasc Res. 2005 Oct;2(4):331-40
16181124
Cancer Res. 2005 Oct 1;65(19):8604-7
16204024
Histol Histopathol. 2006 Jan;21(1):103-24
16267791
Curr Neurovasc Res. 2005 Dec;2(5):387-99
16375720
Curr Neurovasc Res. 2005 Dec;2(5):425-46
16375723
Ann Hematol. 2006 Feb;85(2):79-85
16132904
J Pharmacol Exp Ther. 2006 Mar;316(3):999-1005
16306273
Nat Genet. 2006 Mar;38(3):320-3
16415884
J Clin Invest. 2006 Mar;116(3):683-94
16511603
Lancet. 2006 Mar 11;367(9513):847-58
16530579
Curr Med Chem. 2006;13(8):883-95
16611073
Free Radic Biol Med. 2006 May 15;40(10):1776-84
16678015
Circ Res. 2006 Jun 9;98(11):1405-13
16645141
Cell Mol Life Sci. 2006 Jun;63(11):1226-35
16568235
Metabolism. 2006 Aug;55(8):1046-52
16839840
Int Urol Nephrol. 2006;38(2):295-310
16868702
Diabet Med. 2006 Aug;23(8):839-44
16911620
Curr Neurovasc Res. 2006 Aug;3(3):187-201
16918383
Brain Res. 2006 Sep 7;1108(1):179-87
16872585
Pediatrics. 2006 Sep;118(3):e635-40
16908620
Diabetes. 2006 Oct;55(10):2863-70
17003354
J Am Soc Nephrol. 2006 Oct;17(10):2812-20
16943306
J Med Genet. 2006 Oct;43(10):798-803
16723389
Acta Pharmacol Sin. 2006 Nov;27(11):1389-94
17049112
Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2660-8
16951046
BMC Genomics. 2006;7:301
17134498
Int J Mol Med. 2007 Feb;19(2):263-72
17203200
Cell Signal. 2007 Mar;19(3):634-45
17045782
Epilepsia. 2007 Jan;48(1):175-81
17241225
Diabetes. 2007 Feb;56(2):295-303
17259372
Neuron. 2007 Feb 1;53(3):387-97
17270735
Curr Neurovasc Res. 2007 Feb;4(1):63-71
17311546
Mediators Inflamm. 2006;2006(5):18061
17392570
Br J Pharmacol. 2007 Apr;150(7):839-50
17339844
Brain Dev. 2007 Jun;29(5):273-80
17071037
J Neurochem. 2007 Apr;101(2):342-54
17402968
J Biol Chem. 2007 Apr 20;282(16):12030-7
17242403
Cell Signal. 2007 Jun;19(6):1150-62
17289346
Curr Med Chem. 2007;14(16):1729-38
17627510
J Neurosci Res. 2000 Jul 1;61(1):21-32
10861796
JAMA. 2000 Dec 27;284(24):3157-9
11135780
J Intern Med. 2001 Mar;249(3):225-35
11285042
Nurs Clin North Am. 2001 Jun;36(2):175-92, v
11382558
Diabetes Res Clin Pract. 2002 May;56(2):115-23
11891019
Oncogene. 2002 Sep 26;21(43):6598-605
12242657
Circulation. 2002 Dec 3;106(23):2973-9
12460881
Nephrol Dial Transplant. 2003 Jan;18(1):141-6
12480972
J Cereb Blood Flow Metab. 2003 Mar;23(3):320-30
12621307
Br J Pharmacol. 2003 Mar;138(6):1107-18
12684267
JAMA. 2004 Jan 21;291(3):335-42
14734596
Arch Intern Med. 2004 Feb 9;164(3):262-76
14769622
Histol Histopathol. 2004 Apr;19(2):495-504
15024710
Diabetes Care. 2004 May;27(5):1028-32
15111515